Sleep apnoea and endothelial dysfunction: An individual patient data meta-analysis
- PMID: 32234658
- DOI: 10.1016/j.smrv.2020.101309
Sleep apnoea and endothelial dysfunction: An individual patient data meta-analysis
Abstract
We performed an individual patient data meta-analysis to investigate the association between obstructive sleep apnoea (OSA) severity and the reactive hyperaemia index (RHI) measured by peripheral arterial tonometry (PAT), a validated measurement of endothelial function, and a strong predictor of late cardiovascular (CV) events. Patients from 12 studies underwent PAT and overnight polysomnography or respiratory polygraphy for suspected OSA. Endothelial dysfunction was defined by a log-transformed RHI<0.51. Subgroup analyses were performed to investigate this relationship in specific populations. Among 730 patients without overt CV disease, 387 (53.0%) had severe OSA (apnoea-hypopnea index ≥30) and 164 (22.5%) exhibited endothelial dysfunction. After adjustment for age, gender, diastolic blood pressure, obesity, diabetes and chronic obstructive pulmonary disease, endothelial dysfunction was associated with severe OSA (odds ratio, OR [95% confidence interval]: 2.27 [1.12-4.60]; p = 0.02), and nocturnal hypoxemia defined by >20 min with oxygen saturation <90% (OR: 1.83 [1.22-2.92]; p = 0.004) or mean oxygen saturation <92% (OR: 1.52 [1.17-1.96]; p = 0.002). On subgroup analyses, the association between severe OSA and endothelial dysfunction was not significant in patients with hypertension, obesity and/or diabetes. Among adults without overt CV disease, severe OSA is independently associated with an increased risk of endothelial dysfunction that may predispose to late CV events.
Keywords: Endothelial function; Obstructive sleep apnoea; Reactive hyperaemia index.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflicts of interest FGag reports personal fees from AIR LIQUIDE SANTE, CIDELEC, RESMED, SEFAM, outside the submitted work; non-financial support from AIR LIQUIDE SANTE, ASTEN SANTE, SEFAM, outside the submitted work. JLP reports grants from AGIRADOM, AIR LIQUIDE FOUNDATION, PHILIPS RESPIRONICS, RESMED, SEFAM, VITALAIR, outside the submitted work; personal fees from AGIRADOM, ITAMAR, JAZZ PHARMACEUTICALS, PHILIPS RESPIRONICS, RESMED, SEFAM, outside the submitted. VB, RT, WT, RA, Mathieu Berger, FGou, MJF, IJD, SL, MLV, MCM, and FR report no conflict of interest.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
